Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Prothrombotic Antibodies Targeting the Spike Protein's Receptor-Binding Domain in Severe COVID-19

Blood blood.2024025010.

https://doi.org/10.1182/blood.2024025010

Published: 2024

Includes: Supplemental data

Journal Articles

Adoption of Prophylaxis in the United States in the Era of Extended Half-Life Factor Concentrates

Lynn M. Malec, MD, Gilbert C. White, MD, Stacy E. Croteau, MD, Dunlei Cheng, PhD, Margaret V. Ragni, MD MPH

Blood (2018) 132 (Supplement 1): 2467.

https://doi.org/10.1182/blood-2018-99-115231

Published: 2018

Journal Articles

Real World Use of Extended Half-Life Products and the Impact on Bleeding Events and Joint Health in the United States

Lynn M. Malec, MD, Char M Witmer, MDMSCE, Julie Jaffray, MD, Peter A. Kouides, MD, Kristina M. Haley, DO, Robert F. Sidonio, Jr., MD, Dunlei Cheng, PhD, Thomas C. Abshire, MD, Gilbert C. White, MD, Margaret V. Ragni, MD MPH

Blood (2018) 132 (Supplement 1): 1195.

https://doi.org/10.1182/blood-2018-99-113956

Published: 2018

Journal Articles

Interaction of kindlin-3 and β 2 -integrins differentially regulates neutrophil recruitment and NET release in mice

Zhen Xu, Jiayi Cai, Juan Gao, Gilbert C. White, II, Fangyuan Chen, Yan-Qing Ma

Blood (2015) 126 (3): 373–377.

https://doi.org/10.1182/blood-2015-03-636720

Published: 2015

Journal Articles

B-cell tolerance regulates production of antibodies causing heparin-induced thrombocytopenia

Yongwei Zheng, Alexander W. Wang, Mei Yu, Anand Padmanabhan, Benjamin E. Tourdot, Debra K. Newman, Gilbert C. White, Richard H. Aster, Renren Wen, Demin Wang

Blood (2014) 123 (6): 931–934.

https://doi.org/10.1182/blood-2013-11-540781

Published: 2014

Includes: Supplemental data

Journal Articles

Role Of B Cell Tolerance In PF4/Heparin Antibody Production

Yongwei Zheng, Alexander W Wang, Mei Yu, PhD, Anand Padmanabhan, MBBS, MA, PhD, Benjamin E Tourdot, PhD, Debra K. Newman, PhD, Gilbert C. White, II, MD, Richard H. Aster, MD, Renren Wen, PhD, Demin Wang, PhD

Blood (2013) 122 (21): 2396.

https://doi.org/10.1182/blood.V122.21.2396.2396

Published: 2013

Journal Articles

DISTINCT ROLES for Rap1b In PLATELET SECRETION and INTEGRIN a IIB b 3 OUTSIDE-In SIGNALING

Guoying Zhang, Binggang Xiang, PhD, Ye Shaojing, Magdalena Chrzanowska-Wodnicka, Andrew J. Morris, PhD, T. Kent Gartner, PhD, Sidney W. Whiteheart, PhD, Gilbert C. White, II II, MD, Susan S. Smyth, MD, PhD, Zhenyu Li, MD, PhD

Blood (2011) 118 (21): 2200.

https://doi.org/10.1182/blood.V118.21.2200.2200

Published: 2011

Journal Articles

How we treat a hemophilia A patient with a factor VIII inhibitor

Christine L. Kempton, Gilbert C. White, II

Blood (2009) 113 (1): 11–17.

https://doi.org/10.1182/blood-2008-06-160432

Published: 2009

Journal Articles

A critical role of Rap1b in B-cell trafficking and marginal zone B-cell development

Yuhong Chen, Mei Yu, Andrew Podd, Renren Wen, Magdalena Chrzanowska-Wodnicka, Gilbert C. White, Demin Wang

Blood (2008) 111 (9): 4627–4636.

https://doi.org/10.1182/blood-2007-12-128140

Published: 2008

Includes: Supplemental data

Journal Articles

Defective angiogenesis, endothelial migration, proliferation, and MAPK signaling in Rap1b-deficient mice

Magdalena Chrzanowska-Wodnicka, Anna E. Kraus, Daniel Gale, Gilbert C. White, II, Jillian VanSluys

Blood (2008) 111 (5): 2647–2656.

https://doi.org/10.1182/blood-2007-08-109710

Published: 2008

Includes: Supplemental data

Journal Articles

Therapeutic expression of the platelet-specific integrin, αIIbβ3, in a murine model for Glanzmann thrombasthenia

Juan Fang, Kairbaan Hodivala-Dilke, Bryon D. Johnson, Lily M. Du, Richard O. Hynes, Gilbert C. White, II, David A. Wilcox

Blood (2005) 106 (8): 2671–2679.

https://doi.org/10.1182/blood-2004-12-4619

Published: 2005

Journal Articles

The use of recombinant factor VIIa in the treatment of bleeding disorders

Harold R. Roberts, Dougald M. Monroe, Gilbert C. White

Blood (2004) 104 (13): 3858–3864.

https://doi.org/10.1182/blood-2004-06-2223

Published: 2004

Journal Articles

Ten-Year Follow-Up of Inhibitor Induction in Previously Untreated Patients (PUPs) on Recombinate.

Louis M. Aledort, MD, Gilbert C. White, II, MD, Georges E. Rivard, MD

Blood (2004) 104 (11): 4004.

https://doi.org/10.1182/blood.V104.11.4004.4004

Published: 2004

Journal Articles

Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors

J. Michael Soucie, Christy Cianfrini, Robert L. Janco, Roshni Kulkarni, Julie Hambleton, Bruce Evatt, Angela Forsyth, Sue Geraghty, Keith Hoots, Tom Abshire, Randall Curtis, Ann Forsberg, Heather Huszti, Margaret Wagner, Gilbert C. White, II

Blood (2004) 103 (7): 2467–2473.

https://doi.org/10.1182/blood-2003-05-1457

Published: 2004

Journal Articles

Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion

Jerry S. Powell, Margaret V. Ragni, Gilbert C. White, II, Jeanne M. Lusher, Carol Hillman-Wiseman, Tom E. Moon, Veronica Cole, Sandhya Ramanathan-Girish, Holger Roehl, Nancy Sajjadi, Douglas J. Jolly, Deborah Hurst

Blood (2003) 102 (6): 2038–2045.

https://doi.org/10.1182/blood-2003-01-0167

Published: 2003

Journal Articles

End-stage liver disease in persons with hemophilia and transfusion-associated infections

Blood (2002) 100 (5): 1584–1589.

https://doi.org/10.1182/blood.V100.5.1584.h81702001584_1584_1589

Published: 2002

Journal Articles

Megakaryocyte-targeted synthesis of the integrin β 3 -subunit results in the phenotypic correction of Glanzmann thrombasthenia

David A. Wilcox, John C. Olsen, Lori Ishizawa, Paul F. Bray, Deborah L. French, Douglas A. Steeber, William R. Bell, Michael Griffith, Gilbert C. White, II

Blood (2000) 95 (12): 3645–3651.

https://doi.org/10.1182/blood.V95.12.3645

Published: 2000

Journal Articles

ERGIC-53 Gene Structure and Mutation Analysis in 19 Combined Factors V and VIII Deficiency Families

Blood (1999) 93 (7): 2261–2266.

https://doi.org/10.1182/blood.V93.7.2261

Published: 1999

NARROW

Prothrombotic Antibodies Targeting the Spike Protein's Receptor-Binding Domain in Severe COVID-19

Adoption of Prophylaxis in the United States in the Era of Extended Half-Life Factor Concentrates

Real World Use of Extended Half-Life Products and the Impact on Bleeding Events and Joint Health in the United States

Interaction of kindlin-3 and β 2 -integrins differentially regulates neutrophil recruitment and NET release in mice

B-cell tolerance regulates production of antibodies causing heparin-induced thrombocytopenia

Role Of B Cell Tolerance In PF4/Heparin Antibody Production

DISTINCT ROLES for Rap1b In PLATELET SECRETION and INTEGRIN a IIB b 3 OUTSIDE-In SIGNALING

How we treat a hemophilia A patient with a factor VIII inhibitor

A critical role of Rap1b in B-cell trafficking and marginal zone B-cell development

Defective angiogenesis, endothelial migration, proliferation, and MAPK signaling in Rap1b-deficient mice

Therapeutic expression of the platelet-specific integrin, αIIbβ3, in a murine model for Glanzmann thrombasthenia

The use of recombinant factor VIIa in the treatment of bleeding disorders

Ten-Year Follow-Up of Inhibitor Induction in Previously Untreated Patients (PUPs) on Recombinate.

Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors

Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion

End-stage liver disease in persons with hemophilia and transfusion-associated infections

Megakaryocyte-targeted synthesis of the integrin β 3 -subunit results in the phenotypic correction of Glanzmann thrombasthenia

ERGIC-53 Gene Structure and Mutation Analysis in 19 Combined Factors V and VIII Deficiency Families

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only